Description

Alfuzosin is a selective α-1 adrenergic receptor antagonist of significant importance in the pharmaceutical industry. This compound is valued for its therapeutic efficacy in treating symptoms associated with benign prostatic hyperplasia (BPH). It is a critical active pharmaceutical ingredient (API) required by pharmaceutical manufacturers and research institutions globally for the production of finished dosage forms and clinical studies.

Application

• Primary Active Pharmaceutical Ingredient (API) in the manufacture of extended-release tablets for the treatment of Benign Prostatic Hyperplasia (BPH).
• Key intermediate in advanced pharmaceutical research and development for urological therapeutics.
• Reference standard in analytical laboratories for quality control and method validation of alfuzosin-based products.
• Raw material for preclinical and clinical studies investigating new formulations or combination therapies.
• Essential component for generic drug manufacturers producing bioequivalent versions of branded alfuzosin medications.

Basic Information

Item	Detail
Product Name	Alfuzosin
CAS No.	81403-80-7
Molecular Formula	C19H27N5O4
Molecular Weight	389.45 g/mol
Synonyms	Alfuzosin Hydrochloride; Alfuzosin HCl; SL 77.0499-10; N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide; Xatral; Uroxatral; Alfuprost; Alfusin; Alfuzosine
EINECS	Contact for details

Quality Control

Our Alfuzosin is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets high-purity pharmaceutical standards, including identity, assay, and impurity profile verification. A Certificate of Analysis (COA) documenting compliance with relevant specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a low-humidity environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Individual impurity: ≤ 0.5% Total impurities: ≤ 1.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.